Thursday, October 20, 2011

Levaquin Bellwether Trials Update

BNA reports that a set of cases (one trial, two plaintiffs) reached a defense verdict in the Levaquin pharma litigation.  Beare v. Johnson & Johnson, N.J. Super. Ct. Law Div., No. ATL-L-196-10, verdict 10/14/11; Gaffney v. Johnson & Johnson, N.J. Super. Ct. Law Div., No. ATL-L-4551-09, verdict 10/14/11).  The cases are consolidated before Judge Carol Higbee of New Jersey, who also oversaw the New Jersey Vioxx litigation.

The allegations are the the manufacturer of the antibiotic did not provide adequate warnings of its potential to cause tendon injuries. There are six more bellwether cases to go. According to BNA there are approximately 1,900 Levaquin cases before Judge Higbee.

I don't have information about how the bellwether cases were picked or why eight is the number.  For an analysis of how judges can do a more rigorous job of using bellwether trials to promote case resolution and equality among litigants, see my latest paper: The Case for "Trial by Formula." 

ADL

October 20, 2011 in Aggregate Litigation Procedures, Informal Aggregation, Pharmaceuticals - Misc., Products Liability, Vioxx | Permalink | Comments (1) | TrackBack (0)

Class Actions: The Latest Evidence of Life

The press is reporting that several persons (independent operators of ATMs and individuals) have filed class action lawsuits against big banks for colluding to raise ATM fees.  Here is are some news reports: CBS, Bloomberg Businessweek, Reuters.  

ADL

October 20, 2011 in Class Actions | Permalink | Comments (0) | TrackBack (0)